GLP-1 Dose Titration Schedules Compared Across Major Brands
Nearly every GLP-1 drug starts low and increases gradually. Here's how the titration timelines differ across semaglutide and tirzepatide products.
By the GLP Semaglutide editorial team · Last updated February 18, 2026
GLP-1 drugs are almost universally titrated — started at a low dose and increased over weeks or months — to reduce gastrointestinal side effects like nausea while the body adjusts. The pace and step sizes differ meaningfully between brands.
Typical pattern
Most labeled schedules increase the dose every four weeks, moving through two to four intermediate steps before reaching the labeled maintenance dose, though exact steps and timing are drug-specific and set by each product's FDA label.
Why clinicians sometimes slow it down
Prescribers can extend time at a given dose step beyond the label's minimum if a patient is having a hard time tolerating side effects — titration schedules on the label describe the fastest allowed pace, not a mandatory one.
Primary sources